Peter Mu
Chief Executive Officer at Teamedon International, Inc.
Profile
Peter Mu is currently the President & Chief Executive Officer at Teamedon International, Inc. Prior to this, he worked as a Study Director at Labcorp Drug Development, Inc. from 2005 to 2008 and as an Associate Director at Lexicon Pharmaceuticals, Inc. from 2008 to 2009.
Dr. Mu holds a doctorate degree from North Carolina State University and an MBA from Carey Business School.
Peter Mu active positions
| Companies | Position | Start |
|---|---|---|
Teamedon International, Inc.
 Teamedon International, Inc. Pharmaceuticals: MajorHealth Technology Teamedon International, Inc. develops novel therapeutics to combat leukemia. The company was founded on May 22, 2017 and is headquartered in Lewes, DE. | Chief Executive Officer | - |
Former positions of Peter Mu
| Companies | Position | End |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2008-12-31 |
| COVANCE INC. | Corporate Officer/Principal | 2008-03-31 |
Training of Peter Mu
| North Carolina State University | Doctorate Degree |
| Carey Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Teamedon International, Inc.
Teamedon International, Inc. Pharmaceuticals: MajorHealth Technology Teamedon International, Inc. develops novel therapeutics to combat leukemia. The company was founded on May 22, 2017 and is headquartered in Lewes, DE. | Health Technology |
- Stock Market
- Insiders
- Peter Mu